title: Bruxism and oral parafunctional hyperactivity in social phobia outpatients.
abstract: Anxiety and selective serotonin reuptake inhibitors (SSRIs) are considered aggravating factors for bruxism. We examined the influence of anxiety, depression and SSRI on bruxism in social phobia (SP). Twenty-three drug naïve, 17 SSRI-treated SP patients and 33 healthy controls underwent a psychiatric assessment and completed Leibowitz Social Anxiety Scale and Beck Depression Inventory. Oral parafunctional activity (PF) was evaluated by TM-dental examination and by a questionnaire. Drug- naïve and SSRI-treated SP patients did not differ on demographic and clinical measures. Awake bruxism, 'JAW PLAY' and at least one PF were more prevalent in SP than in controls. Severity of SP predicted the presence of PF. SP, but not depression, was associated with higher risk of oral PF and awake bruxism. Chronic SSRI treatment of SP did not affect sleep and awake bruxism. Dental and anxiety screening may improve the prognosis psychiatric and dental patients. Effective treatment of SP may mitigate bruxism.
authors.affiliation: Geha Mental Health Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: H
authors.initials: H
authors.lastname: Hermesh
authors.forename: L
authors.initials: L
authors.lastname: Schapir
authors.forename: S
authors.initials: S
authors.lastname: Marom
authors.forename: R
authors.initials: R
authors.lastname: Skopski
authors.forename: E
authors.initials: E
authors.lastname: Barnea
authors.forename: A
authors.initials: A
authors.lastname: Weizman
authors.forename: E
authors.initials: E
authors.lastname: Winocur
mesh_terms: D000328:Adult; D014151:Anti-Anxiety Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001007:Anxiety / Q000150:complications* / Q000628:therapy; D002012:Bruxism / Q000209:etiology* / Q000523:psychology / Q000628:therapy; D003863:Depression / Q000150:complications* / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D010698:Phobic Disorders / Q000150:complications* / Q000523:psychology / Q000628:therapy; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D014151:Anti-Anxiety Agents; D017367:Selective Serotonin Reuptake Inhibitors
keywords: bruxism; clenching; depression; selective serotonin reuptake inhibitors; social phobia